Final product composition after ex-vivo T-cell reduction: Miltenyi CliniMACS versus Baxter Isolex 300I in a large cohort of allogeneic trans-plant patients
| Autor: | M. Malloy, R.C. Meagher, Sharon Bleau, Katherine Smith, Peter Maslak, Ann A. Jakubowski, Melissa S. Pessin, Sergio Giralt, Xiaoshe Chen, Sean M. Devlin, Nancy H. Collins, R.J. O'Reilly, Jo-ann Tonon, Guenther Koehne |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Cancer Research
Transplantation Pediatrics medicine.medical_specialty business.industry T cell Immunology Final product Cell Biology Composition (combinatorics) Large cohort Andrology Reduction (complexity) medicine.anatomical_structure Oncology medicine Immunology and Allergy business Genetics (clinical) Ex vivo |
| Zdroj: | Cytotherapy. 15:S22-S23 |
| ISSN: | 1465-3249 |
| DOI: | 10.1016/j.jcyt.2013.01.083 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect